ОбзорГрафикНовостиTraderScreen

Morgan Stanley Call 27 LXS 21.06..../  DE000MB8GHZ4  /

Stuttgart
09.05.2024  12:58:21 Изменение+0.22 Бид13:05:57 Предложение13:05:57 Базовый актив Цена исполнения Дата истечения Тип опциона
1.26EUR +21.15% 1.26
Величина цены спроса: 15,000		 1.35
Величина цены предложения: 15,000		 LANXESS AG 27.00 EUR 21.06.2024 Call
GlobeNewswire 13:20 Vital Farms Reports First Quarter 2024 Financial Results
GlobeNewswire 13:19 Kingsoft Cloud to Report First Quarter 2024 Financial Results on May 22, 2024
GlobeNewswire 13:15 Verona Pharma Reports First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 13:15 ADC Therapeutics to Participate in 2024 RBC Capital Markets Global Healthcare Conference
TeleTrader 13:10 WBD's Q1 revenue down by 7% to $9.9 billion
TeleTrader 13:05 10 injured as Boeing 737 slid off runway in Senegal
GlobeNewswire 13:04 Standard Lithium Reports Fiscal Third Quarter 2024 Results, Schedules Investor Update Call
GlobeNewswire 13:02 Xometry Reports First Quarter 2024 Results
GlobeNewswire 13:01 Nevada Copper Files Financial Statements and MD&A for the Quarter Ended March 31, 2024
GlobeNewswire 13:01 Prelude Therapeutics to Participate in Citizens JMP Life Sciences Conference
GlobeNewswire 13:01 HOOKIPA Pharma Reports First Quarter 2024 Financial Results and Recent Business Highlights
GlobeNewswire 13:00 Tower Semiconductor Reports 2024 First Quarter Financial Results
GlobeNewswire 13:00 Allegro MicroSystems Reports Fourth Quarter and Fiscal Year 2024 Results
GlobeNewswire 13:00 Renalytix to Report Financial Results for Third Quarter Fiscal Year 2024 on May 15
TeleTrader 13:00 BoE keeps its interest rate at 5.25% again
GlobeNewswire 13:00 Lifetime Brands, Inc. Reports First Quarter 2024 Financial Results
GlobeNewswire 13:00 Wave Life Sciences Announces Appointment of Dr. Erik Ingelsson as Chief Scientific Officer
GlobeNewswire 13:00 BioXcel Therapeutics Reports First Quarter 2024 Financial Results
GlobeNewswire 13:00 Monte Rosa Therapeutics Announces First Quarter 2024 Financial Results and Provides Corporate Update
GlobeNewswire 13:00 Lantronix to Participate in the 19th Annual Needham Technology, Media, & Consumer Investor Conferenc...
GlobeNewswire 13:00 First Wave BioPharma and Celiac Journey to Host Nasdaq Event in Support of Celiac Disease Awareness ...
GlobeNewswire 13:00 NOWPayments Enables Cryptocurrency Purchases of Tangem Wallets: Expanding Payment Options with BTC, ...
GlobeNewswire 13:00 Alector to Participate in Upcoming Healthcare Conferences
GlobeNewswire 13:00 Verona Pharma Announces $650 Million Strategic Financing with Oaktree and OMERS
GlobeNewswire 13:00 Royalty Pharma Reports First Quarter 2024 Results